Synonyms: ARO-APOC3
Compound class:
Nucleic acid
Comment: Plozasiran (ARO-APOC3) is a small interfering RNA (siRNA) class ligand. The molecule contains modified nucleotides to improve stability, and it is congugated with N-acetylgalactosamine (GalNAc; at the R1 position), which binds to asialoglycoprotein receptors expressed on hepatocyte membranes to promote delivery of the drug to the liver [4]. Once bound, the siRNA is internalised in lysosomes and is subsequently released into the cytosol. Plozasiran blocks synthesis of apolipoprotein C-III (APOC3), as a mechanism to reduce dyslipidemia that is linked to cardiovascular disease risk [1-2,5].
We have been unable to locate a full chemical SMILES for the ligand, or its HELM notation. |
Classification ![]() |
|
Compound class | Nucleic acid |
Compound subclass | |
Target | apolipoprotein C-III (APOC3) mRNA |
International Nonproprietary Names ![]() |
|
INN number | INN |
13041 | plozasiran |
Synonyms ![]() |
ARO-APOC3 |
Database Links ![]() |
|
CAS Registry No. | 2379776-40-4 (source: WHO INN record) |
DrugBank Ligand | DB18997 |
GtoPdb PubChem SID | 504705461 |
Search PubMed clinical trials | plozasiran |
Search PubMed titles | plozasiran |
Search PubMed titles/abstracts | plozasiran |